Wart treatment with anthralin.
In order to investigate the efficacy of anthralin ( Anthraderm ) in the treatment of warts a randomized controlled trial was carried out in 72 patients. During a two-month period of treatment 56% were cured in the group treated with anthralin 2% ( Anthraderm ), evaluated at follow-up 2-9 months after finishing treatment, compared with 26% in the group treated with the comparative drug ( Verucid ). Anthralin 2% ( Anthraderm ) was found to have a significantly better effect, especially in the group of patients with warts solely on the hands.
D000293:Adolescent; D000328:Adult; D000873:Anthracenes / Q000627:therapeutic use*; D000875:Anthralin / Q000627:therapeutic use*; D002648:Child; D002986:Clinical Trials as Topic; D003300:Copper / Q000627:therapeutic use*; D004338:Drug Combinations / Q000627:therapeutic use; D006801:Humans; D007773:Lactates / Q000627:therapeutic use; D019344:Lactic Acid; D008875:Middle Aged; D009942:Organometallic Compounds; D010936:Plant Extracts / Q000627:therapeutic use*; D011897:Random Allocation; D012459:Salicylates / Q000627:therapeutic use*; D012871:Skin Diseases / Q000188:drug therapy*; D014860:Warts / Q000188:drug therapy*
D000873:Anthracenes; D004338:Drug Combinations; D007773:Lactates; D009942:Organometallic Compounds; D010936:Plant Extracts; D012459:Salicylates; C011564:lactic acid, salicylic acid drug combination; D019344:Lactic Acid; D003300:Copper; D000875:Anthralin